Literature DB >> 23172608

'Hard,' 'soft' and 'surrogate' endpoints in diabetes.

John S Yudkin, Emma M Eggleston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23172608     DOI： 10.1136/jech-2012-201361

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN： 0143-005X            Impact factor:   3.710


× No keyword cloud information.
  4 in total

Review 1.  Glycemic Control for Patients With Type 2 Diabetes Mellitus: Our Evolving Faith in the Face of Evidence.

Authors:  René Rodríguez-Gutiérrez; Victor M Montori
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2016-08-23

2.  Need for better reporting of trials with surrogate endpoints: SPIRIT|CONSORT-SURROGATE extensions.

Authors:  Oriana Ciani; Anthony Manyara; Rod S Taylor
Journal:  J Epidemiol Community Health       Date:  2022-06-24       Impact factor: 6.286

Review 3.  Is HbA1c a valid surrogate for mortality in type 2 diabetes? Evidence from a meta-analysis of randomized trials.

Authors:  Christina Baechle; Wiebke Scherler; Alexander Lang; Tim Filla; Oliver Kuss
Journal:  Acta Diabetol       Date:  2022-05-09       Impact factor: 4.087

Review 4.  Inequalities in health care among patients with type 2 diabetes by individual socio-economic status (SES) and regional deprivation: a systematic literature review.

Authors:  Olga Grintsova; Werner Maier; Andreas Mielck
Journal:  Int J Equity Health       Date:  2014-06-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.